Company Press Releases

Amarc applies to drill seven significant porphyry copper targets - Completes key property purchase at IKE while Centerra relinquishes option

2017-01-11 / @newswire

VANCOUVER, Jan. 11, 2017 /CNW/ - Amarc Resources Ltd. ("Amarc" or the "Company") (TSX-V: AHR; OTCBB: AXREF) announces that Thompson Creek Metals Company Inc. ("TCMC"), which was recently acquired by gold-focused Centerra Gold Inc., has relinquished its option to earn up to a 50% interest in the IK...Read More

PharmAthene Reports Year-End 2016 Financial and Operational Results

2017-03-14 / @newswire

ANNAPOLIS, Md., March 14, 2017 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results for the year ended December 31, 2016. Fourth quarter and subsequent operational highlight...Read More

Unaware of Any Material Change

2017-04-21 / @thenewswire

(TheNewswire) Toronto, ON / TheNewswire / April 21, 2017 - At the request of IIROC, Alturas Minerals Corp. wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity. Alturas Mine...Read More

Altimmune Completes Merger with PharmAthene Creating Immunotherapeutics Company Targeting Infectious Diseases

2017-05-04 / @nasdaq

GAITHERSBURG, Md., May04, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT) announced today the completion of its merger with PharmAthene, Inc., effective May 4, 2017. Upon the completion of the merger, the combined company was renamed Altimmune, Inc., and will commence trading on The NASDAQ C...Read More

Altimmune Promotes Dr. Sybil Tasker to Chief Medical Officer

2017-05-16 / @nasdaq

GAITHERSBURG, Md., May16, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced the promotion of Sybil Tasker, M.D., FACP, FIDSA, to the position of Chief Medical Officer.Dr. Tasker joined the company in April 2016 as Senior Vice Presid...Read More

Altimmune to Provide Corporate Update at the BIO International Convention

2017-06-19 / @nasdaq

GAITHERSBURG, Md., June19, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that Bill Enright, President and Chief Executive Officer of Altimmune, will present a corporate overview at the BIO International Convention, taking place...Read More

Altiplano Minerals Appoints VP Exploration

2017-05-24 / @marketwired

EDMONTON, ALBERTA--(Marketwired - May 24, 2017) - Altiplano Minerals Ltd. (TSX VENTURE:APN) ("APN" or the "Company") is pleased to announce the appointment of Osbaldo Zamora Vega as VP, Exploration. Mr. Zamora has a B.Sc. in Geology from the Autonomous University of San Luis P...Read More

Altiplano Minerals Announces Trading on the OTCQB

2017-05-30 / @marketwired

EDMONTON, ALBERTA--(Marketwired - May 29, 2017) - Altiplano Minerals Ltd. (TSX VENTURE:APN)(OTCQB:ALTPF) ("APN" or the "Company") is pleased to announce that its common shares are now trading on the OTCQB Venture Market in the United States under the symbol "ALTPF". The OTCQB Ve...Read More

CORRECTION: Altiplano Minerals Announces Trading on the OTCQB and Frankfurt Exchange

2017-05-30 / @marketwired

EDMONTON, ALBERTA--(Marketwired - May 30, 2017) - In the news release, "Altiplano Minerals Announces Trading on the OTCQB," issued earlier today by Altiplano Minerals Ltd. (TSX VENTURE:APN)(OTCQB:ALTPF)(FRANKFURT:9AJ1), we are advised by the company that the headline should read...Read More

Altiplano Announces Initial Farellon Drill Results and Operations Update

2017-06-13 / @marketwired

TORONTO, ONTARIO--(Marketwired - June 13, 2017) - Altiplano Minerals Ltd. (TSX VENTURE:APN)(OTCQB:ALTPF)(FRANKFURT:9AJ1) ("APN" or the "Company") is pleased to announce a project update including initial Copper results from the chip sampling and drilling at the Farellon Cu-Au vei...Read More

Altiplano Minerals Ltd. Samples 25 Au g/t over 1.6m at Maria Luisa

2017-06-21 / @nasdaq

VANCOUVER, British Columbia, June21, 2017(GLOBE NEWSWIRE) -- Altiplano Minerals Ltd. (TSX-V:APN) (OTCQB:ALTPF) (FWB:9AJ1) ("APN" or the "Company") is pleased to announce that the Comet Joint Venture (CJV) has commenced fieldwork at its Maria Luisa Project, approximately 100 km north of La Serena,...Read More

Sun Pharma Announces Data from Tildrakizumab Clinical Development Program to be Presented at the 2017 American Academy of Dermatology Meeting

2017-03-01 / @newswire

MUMBAI, India and PRINCETON, N.J., March 1, 2017 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries or associate companies) today announced that several new analyses from Phase-1 and the p...Read More

Devonshire Research Group Issues In-Depth Analysis of Allied Minds

2017-04-20 / @newswire

NEW YORK, April 20, 2017 /PRNewswire/ -- On April 7, 2017, Devonshire Research Group issued an in-depth analysis of Allied Minds (LON: ALM), a Boston-based venture firm trading on the London Stock Exchange with investments in the life science and technology sectors. The report describes the ration...Read More

ThermiGen (R) Advances Global Expansion of ThermiRF (R) Aesthetic Applications

2017-05-02 / @newswire

IRVING, Texas, May 2, 2017 /PRNewswire/ -- ThermiGen, LLC, an innovative aesthetics and women's health medical device company, is pleased to announce their newest indication for the ThermiRF (R) Temperature Controlled Radiofrequency System. The ThermiVa (R) procedure for treatment of so...Read More

Sun Pharma Announces US FDA Filing Acceptance of Biologics License Application (BLA) For Tildrakizumab

2017-05-24 / @newswire

MUMBAI, India and PRINCETON, N.J., May 24, 2017 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries or associate companies) announces the U.S. Food and Drug Administration (FDA) acceptance...Read More

Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok